1.
J Drugs Dermatol
; 20(1): 106-108, 2021 01 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33400408
RESUMO
Case Scenerio: A 26-year-old patient presents to the dermatology clinic with severe nodulocystic scarring acne. The patient identifies as a transgender male and notes that he has been receiving hormone replacement therapy for the past 4 years with weekly intramuscular testosterone injections.